Scienture Holdings, Inc. announced a securities purchase agreement with institutional investors for the purchase of 3,225,000 shares of common stock.
The offering price is set at $1.20 per share, with expected gross proceeds of approximately $3.9 million.
The offering is scheduled to close on August 15, 2025, subject to customary closing conditions.
Offer Details
3,225,000 shares of common stock offered at $1.20 per share.
Gross Proceeds
Expected gross proceeds of approximately $3.9 million before deducting fees.
Closing Date
Offering expected to close on August 15, 2025.
Placement Agent
Maxim Group LLC is the sole placement agent for the offering.
- The offering is being made pursuant to an effective shelf registration statement on Form S-3.
- The shares may only be offered by means of a prospectus supplement filed with the SEC.
- This offering provides an opportunity for institutional investors to support Scienture Holdings, Inc.'s growth strategy.
Scienture Holdings, Inc.'s entrance into a securities purchase agreement marks a significant step in raising capital for its pharmaceutical operating companies.